基于智能手机的个性化炼计划对帕金森病中自我定义的运动任务的影响:长期可行性研究
Lisa Lützow1, Isabelle Teckenburg1, Veronika Koch2
1Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.
Journal of patient-reported outcomes
|October 30, 2023
概括
这项研究表明,使用智能手机应用程序进行6-8个月的家庭数字炼计划对于帕金森病 (PD) 患者来说是可行的和可以接受的,改善了日常活动和生活质量.
科学领域:
- 神经学 神经学
- 数字健康数字健康
- 康复医学 康复医学 康复医学
背景情况:
- 运动治疗对于帕金森病 (PD) 运动障碍至关重要.
- 由于COVID-19大流行,需要远程康复解决方案.
- 数字化,家庭运动计划为PD管理提供了一个有前途的替代方案.
研究的目的:
- 评估PD患者的数字,家庭,高频运动计划的长期接受度.
- 探索这种远程康复方法的初始有效性.
- 在现实环境中评估可用性和患者报告的结果.
主要方法:
- 一项为期6-8个月的受控干预可行性研究,涉及32名PD患者 (16名智能手机组,16名对照组).
- 智能手机组使用了治疗师监督的个性化应用程序来进行家庭运动.
- 结果包括系统可用性量表 (SUS),移动应用评分量表 (uMARS),UPDRS-III,步态参数,PDQ-39和日常生活的运动活动 (M-ADL).
主要成果:
- 观察到高粘附率 (74.5%) 和优秀的可用性 (SUS 84%, uMARS >3.5/5).
- 在智能手机组,患者定义的M-ADL改善了15.5%.
- 虽然UPDRS-III在智能手机组中保持稳定,但在对照组中恶化;PDQ-39的移动性下降在智能手机组中不那么明显.
结论:
- 对于PD患者来说,长期的数字炼计划是可行的和可以接受的.
- 这种方法为标准多巴胺治疗提供了成本效益高,个性化的补充.
- 个性化数字培训证明了日常生活和生活质量中运动功能的好处.
相关概念视频
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567


